News

Exclusive Market Study Estimates that Injectable Drug Delivery Market will Grow at 12.8% CAGR During 2019 – 2026 | Analysis by Baxter, ELI Lilly, Terumo, Becton, Pfizer, Teva

Injectable Drug Delivery Market
Injectable Drug Delivery Market

This comprehensive Injectable Drug Delivery Market research report 2019 – 2026 includes a brief on these trends that can help the businesses operating in the industry to understand the market and strategize for their business expansion accordingly. The research report analyzes the market size, industry share, growth, key segments, CAGR and key drivers.

Overview of the Global Injectable Drug Delivery Market:

The Global Injectable Drug Delivery Market is expected to grow from $404.14 Billion in 2017 to reach $1199.89 Billion by 2026 with a CAGR of 12.8%.

Increasing prevalence of chronic diseases, expansion in the biologics market and technological advances in the form of nanotechnologies are some of the factors propelling the market growth. However, growing injuries and the infections caused by needles is hampering the market growth.

Get a Sample Copy of this Report @ https://marketprognosis.com/sample-request/16637 .

Drug Delivery is the method of administering a pharmaceutical compound into the body through different routes to achieve a therapeutic effect. Oral, injection-based, transdermal, and carrier-based are some of the types of drug delivery devices. Injectable drug delivery facilitates the rapid transport of a drug into the body by passing first-pass metabolism. It also helps in administering drugs in unconscious and comatose patients. It is used in conditions such as hormonal imbalance, cystic fibrosis, autoimmune diseases, pain, Wilson’s disease, hemophilia, hepatitis C and ribose-5-phosphate isomerase deficiency.

Based on formulation packaging, Ampules segment has a significant growth in the market owing to its good barrier properties as compared to other types of packaging. In addition they offer better protection at a lesser cost, ease of transportation and low costs of manufacturing are the factors driving the market in this segment.

Geographically, North America was estimated to be the largest share for the market during the forecast period. The growth is attributed to the rising dominance of chronic diseases and the number of companies that are focused on collaboration and partnerships to ensure the availability of high-value products.

Purchase this report online with Top Key Players Analysis and List of Tables & Figure @ https://marketprognosis.com/buyReport/16637 .

Major Key Players:

1 Baxter International, Inc.

2 ELI Lilly and Company

3 Terumo Corporation

4 Becton

5 Dickinson and Company

6 Pfizer, Inc.

7 Gerresheimer AG

8 Teva Pharmaceutical Industries Ltd.

9 Schott AG

10 Antares Pharma, Inc. and More……………………

Request a Discount on standard prices of this premium report @ https://marketprognosis.com/discount-request/16637 .

In the end, this report covers data and information on capacity and production overview, production, market share analysis, sales overview, supply, sales, and shortage, import, export and consumption as well as cost, price, revenue and gross margin of Injectable Drug Delivery Market.

Table of Contents:

1 Executive Summary

2 Preface

3 Market Trend Analysis

4 Porters Five Force Analysis

5 Global Injectable Drug Delivery Market, By Type

6 Global Injectable Drug Delivery Market, By Formulation Packaging

7 Global Injectable Drug Delivery Market, By Usage Pattern

8 Global Injectable Drug Delivery Market, By Facility of Use

9 Global Injectable Drug Delivery Market, By Site of Administration

10 Global Injectable Drug Delivery Market, By Application

11 Global Injectable Drug Delivery Market, By Distribution Channel

12 Global Injectable Drug Delivery Market, By End User

13 Global Injectable Drug Delivery Market, By Geography

14 Key Developments

15 Company Profiling

Contact us:

ProgMark Pvt. Ltd.

Thane – 421501

India.

[email protected]

+1 973 241 5193

https://www.marketprognosis.com